Bayer announced the launch of vericiguat (Verquvo), a soluble guanylate cyclase (sGC) stimulator, in India. Vericiguat is indicated, along with guideline-based medical therapy, in adults with symptomatic chronic heart failure with reduced ejection...
Torrent Pharmaceuticals Limited (Torrent Pharma) has entered into definitive agreements to acquire 100% of Curatio Healthcare (I) Private Limited (Curatio) for Rs. 2,000 crore. The consideration includes Rs. 115 crore (on the date of signing) of ...
This new age has been propelled by startups, who have invented new tools, and software to bring compounds to market more quickly, more affordably, and more effectively than before. In this article, we examine the benefits of using AI to drug discover
The European Commission said it had secured over 10,000 tecovirimat vaccines against monkeypox, despite the declining number of cases in the European Union (EU)...
PAG, a leading global investment firm, along with consortium partners CX Partners and Samara Capital, has acquired a controlling stake in the Optimus Group, a Hyderabad, based pharmaceutical firm, through the API platform Sekhmet Pharmaventures...
Pfizer Inc and its German partner BioNTech sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years...
Swiss firm Ferring Pharmaceuticals plans to invest an additional Rs 500 crore in expanding the manufacturing of gastrointestinal (GI) drugs in India over the next three years. The company has pumped Rs 500 crore into an active pharmaceutical...
Drug firm Lupin on Thursday said it has received approval from the US health regulator to market a generic non-steroidal anti-inflammatory drug in the American market. The company has received approval from the US Food and Drug Administration for...
Cell and gene therapies are going to be catalysts of paradigm shifts in the global healthcare arena. Both cell and gene therapies are overlapping fields having similar therapeutic objectives. And it targets DNA or RNA outside the body and both th...
BridgeBio Pharma along with Sentynl Therapeutics has received marketing authorisation from the European Commission for a medication to treat a rare disease, according to a joint statement issued on Tuesday. The companies have received approval for...
, CDSCO.jpg)
